Brief: Kazia Therapeutics Says Paxalisib Awarded Fast Track Designation By United States FDA
07/07/2023 02:17
July 7 (Reuters) - Kazia Therapeutics KZA.AX :
* PAXALISIB AWARDED FAST TRACK DESIGNATION BY UNITED STATES
FOOD
AND DRUG ADMINISTRATION
Source text for Eikon: ID:nASX6SjwtG
Further company coverage: KZA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kazia Therapeutics
See all newsBrief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Kazia Announces Voluntary Delisting From ASX
Australia's Kazia Therapeutics slumps to 1-yr low on delisting announcement
Brief: Kazia Therapeutics Announces Intention To Voluntarily De-List From ASX
Brief: Kazia Therapeutics Seeks Trading Halt